Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends. It was a contrast to how Cole, 18, spent part of the 2024 holiday season. She was in the hospital — a frequent occurrence with sickle cell disease, a genetic condition that damages oxygen-carrying red…
Serenity Cole pasó las fiestas del pasado diciembre descansando con su familia cerca de su casa en St. Louis, haciendo manualidades y visitando amigos. Fue muy diferente a la temporada navideña de 2024, cuando estuvo hospitalizada, algo frecuente debido a la anemia falciforme, una enfermedad genética que daña los glóbulos rojos encargados de transportar oxígeno,…
When I was at HLTH last October Bradley Bostic invited me on his BoomBostic Health podcast. I was in the mood for ranting about the health care system and promoting my desire for getting everyone concierge level primary care. Bradley was very generous in giving me a mike and a lot of rope. I am…
That is according to the 2024 national health expenditure data published in Health Affairs last week (Hartman et al. 2026). Here is the abstract: Health care spending in the US reached $5.3 trillion and increased 7.2 percent in 2024, similar to growth of 7.4 percent in 2023, as increased demand for health care influenced this two-year trend. As…
French startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear EEG device. The system seeks to improve care for neurological conditions like epilepsy, Alzheimer’s and sleep disorders by capturing brain activity in everyday settings that traditional scalp-based EEGs often miss. The post French Startup Gains FDA Clearance…
Angle Health and Leap Health partnered to offer more affordable, at-home infusion care to small employers. The post Angle Health, Leap Health Team Up to Bring More Affordable Infusion Care to Employers appeared first on MedCity News.
Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore. The post UPMC Enteprises’ Biopharma Lead: We are At a Tipping Point When it Comes to China appeared first on MedCity News.
Rapt Therapeutics brings to GSK ozureprubart, a long-acting antibody that inhibits the validated immunology target immunoglobulin E (IgE). If GSK is able to bring this drug to the market, it would complete with the blockbuster Genentech and Novartis allergy drug Xolair. The post GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in…
Cynthia Freeman, una artista de 61 años que vive en Nueva York, lleva tiempo tratando de encontrar la manera de mantener el plan médico de la Ley de Cuidado de Salud a Bajo Precio (ACA, en inglés) del que dependen ella y su esposo. “Si no tuviéramos problemas de salud, volvería a lo que hacía…
From the heavy emphasis on limiting all ultra-processed foods and eliminating added sugars to placing saturated fats at the top of the pyramid, the new DGAs provide a framework, but highlight areas that still need nuance, clarity, and practical context. The post Reading Between the Lines of the New Dietary Guidelines appeared first on MedCity…